Search

everythinglearnresearchcommunity

for

Search:↓

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Geography affects skin microbiome more than genetics, but genetics still play a role.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

A woman with thymoma developed a rare chronic condition similar to graft versus host disease after surgery.

CXCL12+ fibroblasts help recruit neutrophils to fight skin infections.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

A new model helps study acne and test treatments.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Engineered vesicles deliver mitochondria to improve diabetic wound healing.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Sarcoptes scabiei infection causes significant health and behavior changes in wombats.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Knowing how skin works and its diseases helps doctors diagnose and treat skin conditions better.

Leprosy is mainly contracted during infancy or childhood.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

PLAU and SerpinB2 affect cell death differently in various forms of leprosy and could be targets for new treatments.

The conclusion is that proper recognition and treatment of skin conditions are crucial for the elderly due to changes in skin, nails, and hair with age, and the impact of these conditions on health and mobility.

The symposium concluded that environmental factors significantly contribute to skin aging.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Entospletinib effectively prevents eye and skin GVHD in mice.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.